🚀 The technology is called High-throughput Stable Pool (HTSP) and it allows for the rapid generation and evaluation of high-producing cell lines.
💼 This technology will help companies in the biopharmaceutical industry to optimize and streamline their cell line development processes.
👩🔬🧪 By reducing the time and resources required for cell line development, HTSP has the potential to expedite the production of biologic drugs.
💉 This development will ultimately benefit patients by making life-saving medications more readily available.
Introduction:
Abzena, a biopharmaceutical company, has launched a new technology aimed at speeding up the process of developing cell lines for biologic drug production.
- The new technology, called Abzena Inside, combines the company’s expertise in protein engineering and its proprietary cell line development platform.
- Abzena Inside uses a high-throughput process to generate a large number of unique cell lines that produce high-quality biologics.
- The technology allows for accelerated clone selection and stability testing, reducing the time and cost involved in developing cell lines for biologic drug production.
- Abzena Inside also includes a suite of analytical services to support cell line development and optimization.
- The technology has the potential to significantly improve the efficiency and speed of the cell line development process, leading to faster production of biologics for various therapeutic applications.
Conclusion:
Abzena’s new technology, Abzena Inside, has the potential to revolutionize the cell line development process for biologic drug production. By combining protein engineering expertise with a high-throughput cell line development platform, Abzena Inside can generate a large number of unique cell lines that produce high-quality biologics. This technology not only accelerates clone selection and stability testing, but also includes analytical services to support cell line development. Overall, Abzena Inside has the potential to significantly improve the efficiency and speed of the cell line development process, leading to faster production of biologics for various therapeutic applications.
